VULVAR CARCINOMA
Clinical trials for VULVAR CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new VULVAR CARCINOMA trials appear
Sign up with your email to follow new studies for VULVAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Targeted drug shows promise for rare vulvar cancer
Disease control Not yet recruitingThis phase 2 trial tests a drug called tisotumab vedotin in people with advanced squamous cell carcinoma of the vulva that has returned or spread. The drug is an antibody-drug conjugate designed to seek out and destroy cancer cells. The study aims to see how many participants' tu…
Matched conditions: VULVAR CARCINOMA
Phase: PHASE2 • Sponsor: GOG Foundation • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New study explores combining cancer and blood vessel surgery for advanced gynecologic tumors
Knowledge-focused Not yet recruitingThis study looks at how well patients do after surgery that removes both advanced gynecologic cancers and the major blood vessels they have grown into. Researchers will track 130 participants for up to 5 years to see survival rates and how long it takes for the cancer to return. …
Matched conditions: VULVAR CARCINOMA
Sponsor: National Cancer Institute, Naples • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC